Overview
Fred Hutchinson Cancer Research Center, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, the Center’s five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Hutchinson Center, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Join us and make a difference!
We currently have a 2-year postdoctoral position available through the Cancer Prevention Department. The National Cancer Institute, as part of its NCI Community Oncology Research Network (NCORP), recently launched a program dedicated to Cancer Care Delivery Research (CCDR). This program encompasses a multidisciplinary field of scientific investigation, fusing health services research and statistical methods to examine how social factors, financing systems, organizational structures and processes, health technologies, and healthcare provider and individual behaviors affect cancer outcomes, access to and quality of care, cancer care costs, and the health and well-being of cancer patients and survivors.
SWOG is a national cancer clinical trials consortium, with a prominent and growing program in cancer care delivery research alongside its treatment and prevention programs. Candidates should have an interest in the investigation of novel research questions through the strategic linkage of independent datasets (i.e. “big data”) as well as in the design of prospective trials to examine cancer care delivery research questions.
Responsibilities
The fellowship is under the direction of Dr. Joseph Unger within the Division of Public Health Sciences. Dr. Unger’s research program includes income disparities in access and outcome within cancer treatment trials; late effects of cancer treatment; the population impact and diffusion of cancer clinical trial-proven new treatments; and the design and analysis of symptom control, quality of life, and cancer care delivery trials.
Qualifications
PhD in Health Services Research, Biostatistics, or equivalent program with strong quantitative and analytic programming skills and an interest in health care delivery and policy.